Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/12083

TDMS Study 99033-02 Pathology Tables

NTP Experiment-Test: 99033-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: 26-39 WEEKS                         TRANSGENIC MODEL EVALUATION II (ASPARTAME)                        Date: 03/05/03
Route: DOSED FEED                                                                                                 Time: 11:32:25

                                                       FINAL #3/P53 MICE




       Facility:  BIORELIANCE

       Chemical CAS #:  22839-47-0

       Lock Date:  07/20/01

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All


































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1


NTP Experiment-Test: 99033-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: 26-39 WEEKS                         TRANSGENIC MODEL EVALUATION II (ASPARTAME)                        Date: 03/05/03    
Route: DOSED FEED                                                                                                 Time: 11:32:25    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         P53+/-(C57BL/6) FEMALE                    VEHICLE      3125 PPM     6250 PPM     12500        25000        50000           
                                                   CONTROL                                PPM          PPM          PPM             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          15           15           15           15           15           15           
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                 1                         1                                                  
    Natural Death                                                   1                                                               
  Survivors                                                                                                                         
    Terminal Sacrifice                                14           14           14           15           15           15           
                                                                                                                                    
  Animals Examined Microscopically                    15           15           15           15           15           15           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Liver                                              (15)         (15)         (15)         (15)         (15)         (15)         
      Infiltration Cellular, Focal, Lymphocyte         4 (27%)      3 (20%)      4 (27%)      6 (40%)      4 (27%)      4 (27%)     
      Necrosis, Focal                                                                                                   1 (7%)      
      Pigmentation, Focal, Hemosiderin                 1 (7%)                                                                       
      Tension Lipidosis                                1 (7%)                                                                       
      Hepatocyte, Necrosis, Focal                                                                          2 (13%)                  
      Hepatocyte, Vacuolization Cytoplasmic, Focal                                                         1 (7%)                   
   Salivary Glands                                    (15)                                                             (15)         
      Infiltration Cellular, Focal, Lymphocyte         6 (40%)                                                          8 (53%)     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (15)         (15)         (14)         (15)         (15)         (15)         
      Hyperplasia, Focal                                                         1 (7%)       1 (7%)       1 (7%)                   
      Subcapsular, Hyperplasia, Focal                 12 (80%)     13 (87%)     13 (93%)     15 (100%)    15 (100%)    15 (100%)    
   Pituitary Gland                                    (9)          (14)         (13)         (14)         (11)         (14)         
      Pars Intermedia, Hypertrophy                                               1 (8%)                    2 (18%)      2 (14%)     
   Thyroid Gland                                      (14)         (13)         (14)         (14)         (13)         (15)         
      Ectopic Thymus                                   2 (14%)      1 (8%)       1 (7%)       3 (21%)      1 (8%)       2 (13%)     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    2                                                              
                                                                                                                                   
NTP Experiment-Test: 99033-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: 26-39 WEEKS                         TRANSGENIC MODEL EVALUATION II (ASPARTAME)                        Date: 03/05/03    
Route: DOSED FEED                                                                                                 Time: 11:32:25    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         P53+/-(C57BL/6) FEMALE                    VEHICLE      3125 PPM     6250 PPM     12500        25000        50000           
                                                   CONTROL                                PPM          PPM          PPM             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Ovary                                              (15)         (15)         (14)         (15)         (15)         (15)         
      Atrophy                                                                    1 (7%)                                             
      Cyst                                             1 (7%)                                                                       
   Uterus                                             (15)         (15)         (15)         (15)         (15)         (15)         
      Hydrometra                                                    1 (7%)                                                          
      Endometrium, Hyperplasia, Cystic                14 (93%)     14 (93%)     15 (100%)    14 (93%)     15 (100%)    15 (100%)    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Lymph Node, Mandibular                             (15)         (13)         (13)         (15)         (15)         (14)         
      Congestion                                                                                           1 (7%)                   
      Hyperplasia                                      1 (7%)       2 (15%)                   1 (7%)       1 (7%)                   
      Hyperplasia, Histiocytic                         1 (7%)                                                                       
      Hyperplasia, Lymphoid                            2 (13%)                                                                      
      Hyperplasia, Plasma Cell                         1 (7%)                                                                       
   Lymph Node, Mesenteric                             (15)         (14)         (14)         (14)         (15)         (15)         
      Hyperplasia                                                   1 (7%)                                                          
      Hyperplasia, Lymphoid                            1 (7%)                                                                       
   Lymph Node, Mediastinal                            (12)         (13)         (13)         (12)         (13)         (15)         
      Hyperplasia, Lymphoid                            1 (8%)                                                                       
   Spleen                                             (15)         (15)         (15)         (15)         (15)         (15)         
      Depletion Cellular, Diffuse                                   1 (7%)                                                          
      Hematopoietic Cell Proliferation                 3 (20%)      4 (27%)      1 (7%)       3 (20%)      1 (7%)       1 (7%)      
      Pigmentation                                                                                         1 (7%)                   
   Thymus                                             (14)         (14)         (14)         (15)         (15)         (15)         
      Atrophy, Focal                                   1 (7%)                                                                       
      Hyperplasia                                                                1 (7%)                                 1 (7%)      
      Hyperplasia, Atypical, Focal                                                            1 (7%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (15)                      (1)                                    (15)         
      Femur, Fibrous Osteodystrophy, Focal                                                                              1 (7%)      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    3                                                              
                                                                                                                                   
NTP Experiment-Test: 99033-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: 26-39 WEEKS                         TRANSGENIC MODEL EVALUATION II (ASPARTAME)                        Date: 03/05/03    
Route: DOSED FEED                                                                                                 Time: 11:32:25    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         P53+/-(C57BL/6) FEMALE                    VEHICLE      3125 PPM     6250 PPM     12500        25000        50000           
                                                   CONTROL                                PPM          PPM          PPM             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (15)         (14)         (14)         (15)         (15)         (15)         
      Medulla, Cyst Epithelial Inclusion                                                      1 (7%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (15)         (15)         (14)         (15)         (15)         (15)         
      Infiltration Cellular, Focal, Lymphocyte         1 (7%)                                              1 (7%)       1 (7%)      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Harderian Gland                                    (15)                                                             (15)         
      Infiltration Cellular, Focal, Lymphocyte         1 (7%)                                                           3 (20%)     
      Inflammation, Chronic Active                                                                                      1 (7%)      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (15)         (14)         (15)         (15)         (15)         (15)         
      Infiltration Cellular, Focal, Lymphocyte                      1 (7%)                    1 (7%)                                
      Glomerulus, Hyalinization                                                                                         1 (7%)      
      Renal Tubule, Dilatation, Diffuse                1 (7%)       2 (14%)      3 (20%)                                            
      Renal Tubule, Dilatation, Focal                  6 (40%)      5 (36%)      2 (13%)      5 (33%)      4 (27%)      4 (27%)     
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page    4                                                              
                                                                                                                                   
NTP Experiment-Test: 99033-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: 26-39 WEEKS                         TRANSGENIC MODEL EVALUATION II (ASPARTAME)                        Date: 03/05/03    
Route: DOSED FEED                                                                                                 Time: 11:32:25    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         P53+/-(C57BL/6) MALE                      VEHICLE      3125 PPM     6250 PPM     12500        25000        50000           
                                                   CONTROL                                PPM          PPM          PPM             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          15           15           15           15           15           15           
  Early Deaths                                                                                                                      
    Natural Death                                      1                         1                         1                        
    Moribund Sacrifice                                                           1                                      1           
  Survivors                                                                                                                         
    Terminal Sacrifice                                14           15           13           15           14           14           
                                                                                                                                    
  Animals Examined Microscopically                    15           15           15           15           15           15           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Liver                                              (15)         (15)         (15)         (15)         (14)         (15)         
      Infiltration Cellular, Focal, Lymphocyte         2 (13%)      2 (13%)      4 (27%)      1 (7%)       2 (14%)      5 (33%)     
      Inflammation, Chronic                            1 (7%)                                                                       
      Inflammation, Chronic Active                     3 (20%)                                                          1 (7%)      
      Necrosis, Focal                                  2 (13%)      1 (7%)                                              1 (7%)      
      Hepatocyte, Periportal, Vacuolization                                                                                         
        Cytoplasmic, Diffuse                           2 (13%)                                                          4 (27%)     
   Salivary Glands                                    (15)         (1)          (1)                       (1)          (15)         
      Infiltration Cellular, Focal, Lymphocyte         9 (60%)      1 (100%)                               1 (100%)    10 (67%)     
   Tooth                                                                                                               (1)          
      Peridontal Tissue, Cyst                                                                                           1 (100%)    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (15)         (15)         (15)         (15)         (15)         (15)         
      Atrophy                                         14 (93%)     14 (93%)     12 (80%)     12 (80%)     10 (67%)     13 (87%)     
      Hypertrophy, Focal                                            1 (7%)       3 (20%)      2 (13%)      1 (7%)       3 (20%)     
      Subcapsular, Hyperplasia, Focal                  1 (7%)                    2 (13%)      1 (7%)       2 (13%)      1 (7%)      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    5                                                              
                                                                                                                                   
NTP Experiment-Test: 99033-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: 26-39 WEEKS                         TRANSGENIC MODEL EVALUATION II (ASPARTAME)                        Date: 03/05/03    
Route: DOSED FEED                                                                                                 Time: 11:32:25    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         P53+/-(C57BL/6) MALE                      VEHICLE      3125 PPM     6250 PPM     12500        25000        50000           
                                                   CONTROL                                PPM          PPM          PPM             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (15)         (15)         (15)         (15)         (14)         (15)         
      Epithelium, Degeneration, Focal                               1 (7%)                                                          
   Testes                                             (15)         (15)         (15)         (15)         (14)         (15)         
      Mineralization, Focal                                         1 (7%)                                                          
      Germinal Epithelium, Degeneration, Diffuse                    1 (7%)                                                          
      Germinal Epithelium, Degeneration, Focal                      1 (7%)                    1 (7%)                                
      Rete Testes, Inflammation, Focal                 1 (7%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (14)                                                             (15)         
      Hyperplasia                                                                                                       1 (7%)      
   Lymph Node                                                                                (1)                                    
      Iliac, Pigmentation, Focal                                                              1 (100%)                              
   Lymph Node, Mandibular                             (14)         (15)         (14)         (15)         (14)         (15)         
      Hyperplasia                                                   3 (20%)                   2 (13%)                               
      Hyperplasia, Plasma Cell                         1 (7%)                                                           2 (13%)     
   Lymph Node, Mesenteric                             (14)         (14)         (15)         (13)         (14)         (15)         
      Hyperplasia                                                                                          1 (7%)                   
   Lymph Node, Mediastinal                            (13)         (14)         (14)         (13)         (12)         (13)         
      Hyperplasia                                                                                          1 (8%)                   
   Spleen                                             (15)         (15)         (15)         (15)         (14)         (15)         
      Atrophy                                          2 (13%)                                                                      
      Hematopoietic Cell Proliferation                                                                     1 (7%)       2 (13%)     
      Hyperplasia, Lymphoid                                                                                             1 (7%)      
   Thymus                                             (14)         (15)         (15)         (14)         (15)         (14)         
      Atrophy, Diffuse                                                                                     1 (7%)                   
      Atrophy, Focal                                                                                                    2 (14%)     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    6                                                              
                                                                                                                                   
NTP Experiment-Test: 99033-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: 26-39 WEEKS                         TRANSGENIC MODEL EVALUATION II (ASPARTAME)                        Date: 03/05/03    
Route: DOSED FEED                                                                                                 Time: 11:32:25    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         P53+/-(C57BL/6) MALE                      VEHICLE      3125 PPM     6250 PPM     12500        25000        50000           
                                                   CONTROL                                PPM          PPM          PPM             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (14)         (15)         (15)         (15)         (14)         (15)         
      Hydrocephalus                                                              1 (7%)                                             
      Corpus Callosum, Medulla, Vacuolization                                                                                       
        Cytoplasmic, Focal                                                       1 (7%)                                             
      Medulla, Vacuolization Cytoplasmic, Focal                                                                         1 (7%)      
      Ventricle, Hydrocephalus                                      1 (7%)                                                          
   Peripheral Nerve                                   (1)                                                                           
      Vacuolization Cytoplasmic, Diffuse               1 (100%)                                                                     
   Spinal Cord                                        (1)                                                                           
      Vacuolization Cytoplasmic, Focal                 1 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (15)         (15)         (15)         (15)         (14)         (15)         
      Infiltration Cellular, Focal, Lymphocyte                                                                          1 (7%)      
      Inflammation, Chronic Active, Diffuse                                      1 (7%)                                             
      Perivascular, Infiltration Cellular,                                                                                          
        Lymphocyte                                                                                         2 (14%)                  
   Nose                                               (14)                                                             (15)         
      Inflammation, Acute                              1 (7%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (14)                      (1)                                    (15)         
      Developmental Malformation                                                 1 (100%)                                           
   Harderian Gland                                    (15)                                                             (15)         
      Infiltration Cellular, Focal, Lymphocyte         5 (33%)                                                          1 (7%)      
      Inflammation, Chronic Active                                                                                      1 (7%)      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (14)         (15)         (15)         (15)         (14)         (15)         
      Infiltration Cellular, Focal, Lymphocyte                      1 (7%)                    1 (7%)                                
      Nephropathy                                      4 (29%)                                                          3 (20%)     
      Renal Tubule, Dilatation, Diffuse                             2 (13%)                   1 (7%)                    1 (7%)      
      Renal Tubule, Dilatation, Focal                               2 (13%)                                                         
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page    7                                                              
                                                                                                                                   
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------